|Company||CryoCath Technologies, Inc.|
|Description|| SurgiFrost is a malleable, single-use cryosurgical probe developed to treat cardiac arrhythmias during open-heart surgery. The probe will ablate cardiac tissue while a patient is undergoing a primary cardiac surgical procedure, such as coronary artery bypass grafting (CABG) or mitral valve (MV) replacement and/or repair and as part of the Maze procedure.
Freezing preserves tissue integrity. And SurgiFrost's malleable probe shaft and flexible tip with adjustable insulation sleeve allow for accurate lesion placement, minimizing inadvertent tissue damage. It also minimizes the risk of endocardial thrombus associated with heat-based energy sources. The tip adheres to the target site when freezing begins for precise lesion positioning on a beating heart. The SurgiFrost system combines the traditional safety of cryoenergy with the speed and flexibility required by today's cardiothoracic surgeons.
The SurgiFrost CryoSurgical Ablation System is quick and easy to set up and the probe is flexible and easy to maneuver. Its 60mm segment can be configured to desired lengths and shapes to produce ideal ablation lines. SurgiFrost can be used with all incision types and in conjunction with any cardiac surgical procedure. Incisions include: full median sternotomy, small sternal incisions and thoracotomy. It can be used in a beating or arrested heart to perform all generally accepted lesion sets.
|Info|| CryoCath Technologies, Inc.|
Customer Service: (877) 464-2796
Web site: http://www.cryocath.com